Medical Expenditure of National Health Insurance Attributable to Smoking among the Korean Population

  • Lee, Sang-Yi (Department of Health Policy and Management, Medical College, Cheju National University) ;
  • Jee, Sun-Ha (Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Metabolic Syndrome Research Initiative) ;
  • Yun, Ji-Eun (Metabolic Syndrome Research Initiative) ;
  • Kim, Su-Young (Department of Preventive Medicine, Medical College, Cheju National University) ;
  • Lee, Ja-Kyung (Institute for Health Promotion, Graduate School of Public Health, Yonsei University) ;
  • Samet, Jonathan M. (Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health) ;
  • Kim, Il-Soon (Korean Association of Smoking and Health)
  • 발행 : 2007.05.31

초록

Objectives : The purpose of this study was to determine the population-attributable risk (PAR) and estimate the total medical expenditure of the Korean National Health Insurance (KNHI) due to smoking. Methods : We used data from the Korean Cancer Prevention Study of 1,178,138 Koreans aged 30 to 95. These data were available from 1992 to 2003 and covered a long-term follow-up period among the Korean population. Results : The total medical expenditure of KNHI related to smoking increased by 27% from $324.9 million in 1999 to $413.7 million in 2003. By specific diseases, smoking-attributable KNHI medical expenditure was the highest for lung cancer ($74.2 million), followed by stroke ($65.3 million), COPD ($50.1 million), CHO ($49 million) and stomach cancer ($30 million). A total of 1.3 million KNHI patients were suffering from smoking-related diseases in 2003. We predicted rises in total KNHI medical expenditure related to smoking to $675.1 million (63% increase compared with that of 2003) and in the total number of KNHI patients suffering from smoking-related diseases to about 2.6million (an approximate 100% increase compared with those in 2003) in 2015. Conclusions : We found a substantial economic burden related to the high smoking prevalence in South Korea.

키워드

참고문헌

  1. U.S. Department of Health Education and Welfare, Smoking and health. Report of the Advisory Committee to the Surgeon General. DHEW Publication No. [PHS] 1103. Washington, DC: U.S. Government Printing Office; 1964. p. 25-26
  2. Boyle P, Maisonneuve P. Lung cancer and tobacco smoking. Lung cancer 1995; 12(3):167- 181 https://doi.org/10.1016/0169-5002(95)00443-5
  3. Doll R. Uncovering the effects of smoking: historical perspective. Stat Methods Med Res 1998; 7(2): 87- 117 https://doi.org/10.1191/096228098668199908
  4. Rijken B, Britton J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir Monogr 1998; 7(1): 41-73
  5. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BM J 1994; 309(6959): 901-911 https://doi.org/10.1136/bmj.309.6959.901
  6. Jeremy JY, Mikhailidis DP, Pittilo RM. Cigarette smoking and cardiovascular disease. J R Soc Health 1995; 115(5): 289-295 https://doi.org/10.1177/146642409511500505
  7. Lee KS, Lee KS, Park JK. The economic Consequences of Smoking in Korea. Institute of Population and Health Services Research. Seoul: Yonsei Univ; 1991. p. 1-19
  8. Park JK, Lee KS. The economic losses of smoking. Korean J Prev Med 1989; 22(4): 528- 541 (Korean)
  9. Kim TH, Moon OR, Kim BY. Estimation of productivity losses due to smoking. Korean J Health Policy Adm 2000; 10(3): 169-187 (Korean)
  10. Kim HJ, Park TK, Jee SH, Kang HY, Nam CM. Analysis of socioeconomic costs of smoking in Korea. Korean J Prev Med 2001; 34(3):183-190 (Korean)
  11. Jee SH, Suh Il, Kim SI, Apprel LJ. Smoking and atherosclerotic cardiovascular disease on men with low levels of serum cholesterol. JAMA 1999; 282(22): 2149-2155 https://doi.org/10.1001/jama.282.22.2149
  12. Jee SH, Samet JM, Ohrr H, Kim JH, Kim IS. Smoking and cancer risk in Korean men and women. Cancer Causes Control 2004;15(4): 341-348 https://doi.org/10.1023/B:CACO.0000027481.48153.97
  13. Jee SH, Jo I, Yun JE, Park JY, Sull JW, Ohrr H, Lee S-Y, Yoon Y, Samet JM, Kim IS. Smoking and cause of death in Korea: 11-year follow-up prospective study. Korean J Epidemiol 2005; 27(1): 182-190 (Korean)
  14. Kang HY, Kim HJ, Park TK, Jee SH, Nam CM, Park HW. Economic burden of smoking in Korea. Tob Control 2003; 12(1): 37-44 https://doi.org/10.1136/tc.12.1.37
  15. Kim JH, Jung JC, Kim SW. Survey on Medical Cost Paid by Patients. National Health Insurance Corporation. Annual Report 2004
  16. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976; 2(6051): 1525- 1536 https://doi.org/10.1136/bmj.2.6051.1525
  17. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BM J 2004; 328(7455): 1519 https://doi.org/10.1136/bmj.38142.554479.AE
  18. Meng KH. Smoking-attributable mortality among Korean adults. Korean J Epidemiol 1988; 10:138-145 (Korean)
  19. Jee SH. Are the Risks of Smoking Different in Asia? In: The 7th Asia Pacific Conference on Tobacco or Health; 2004 Sep 15-18; Gyeongju: 2004. p. 82-88
  20. Korean National Tuberculosis Association. Surveys on the smoking habits in Korea, 1980 and 1985. Tuberculosis and Respiratory Diseases 1987; 34(2) 109-123 (Korean)
  21. Liu BQ, Peto R, Chen Z-M, Boreham J, Wu Y, Li J, Campbell TC, Chen JS. Emerging tobacco hazards in China: Retrospective proportional mortality study of one million deaths. BMJ 1998; 317(7170): 1411-1422 https://doi.org/10.1136/bmj.317.7170.1411